StockNews.com initiated coverage on shares of Kamada (NASDAQ:KMDA – Get Rating) in a research note issued to investors on Wednesday morning. The firm issued a buy rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $11.00 price objective on shares of Kamada in a report on Thursday, March […]